SCHEMBL17923675

SCHEMBL17923675

Brc1ccc2c(c1)C1(c3ccccc3-c3ccccc31)c1ccc(-c3ccccc3-c3ccccc3)cc1-2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 7/20 0.44
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PTPRC P08575 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ RARB P10826 1/20 0.33
▸ RARG P13631 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ XBP1 P17861 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17923649 0.94 PDK2 (0.40) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL5763937 0.91 PDK2 (0.46) PDK2ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL5761084 0.89 PDK2 (0.50) PDK2ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL5762894 0.89 PDK2 (0.50) PDK2ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL19001890 0.86 PDK2 (0.48) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL14189338 0.86 PDK2 (0.50) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL30823857 0.86 PDK2 (0.50) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL26369373 0.86 MAPK1 (0.45) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL22797311 0.86 MAPK1 (0.45) PDK2ALDH1A1MAPK1MEN1LMNA
SCHEMBL26155068 0.86 PDK2 (0.50) PDK2ALDH1A1MAPK1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF POP1, TERB1, AP2B1 PDK2 2688/4885ALDH1A1 2052/4885MAPK1 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback